Keyue Liu Selected Research

Histamine H2 Receptors

3/2007	Histaminergic involvement in neuropathic pain produced by partial ligation of the sciatic nerve in rats.
3/2005	Prevention of brain infarction by postischemic administration of histidine in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keyue Liu Research Topics

Disease

18	Inflammation (Inflammations) 07/2023 - 12/2005
15	Ischemia 01/2016 - 12/2002
10	Pain (Aches) 01/2024 - 01/2016
9	Neuralgia (Stump Neuralgia) 08/2022 - 03/2007
8	Reperfusion Injury 02/2011 - 02/2004
7	Sepsis (Septicemia) 12/2021 - 07/2008
6	Brain Injuries (Brain Injury) 01/2022 - 09/2006
6	Brain Infarction 05/2011 - 03/2005
6	Infarction (Infarctions) 02/2011 - 06/2003
5	Hypersensitivity (Allergy) 01/2022 - 01/2013
5	Infections 12/2021 - 06/2015
5	Pneumonia (Pneumonitis) 01/2019 - 06/2015
5	Brain Edema (Cerebral Edema) 10/2017 - 09/2008
4	Brain Ischemia (Cerebral Ischemia) 01/2021 - 12/2005
4	Stroke (Strokes) 01/2021 - 01/2013
4	Hyperalgesia 01/2018 - 01/2016
3	Neuroinflammatory Diseases 01/2022 - 01/2016
3	Edema (Dropsy) 10/2018 - 09/2008
3	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2014 - 09/2012
2	Trigeminal Nerve Diseases (Trigeminal Nerve Disorders) 01/2024 - 04/2021
2	Cytokine Release Syndrome 07/2023 - 07/2016
2	Shock 01/2022 - 12/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2021 - 10/2018
2	Human Influenza (Influenza) 12/2021 - 01/2019
2	Chronic Pain 04/2021 - 01/2013
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020 - 01/2017
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 05/2011
2	Thromboinflammation 10/2018 - 07/2016
2	Pancreatitis 10/2018 - 12/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 02/2016 - 01/2016
2	Diabetes Complications 09/2010 - 03/2010
2	Ischemic Stroke 01/2009 - 12/2007
2	Hepatic Encephalopathy 10/2007 - 04/2005
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2007 - 04/2005
1	Carcinoma (Carcinomatosis) 01/2024
1	Carcinogenesis 01/2024
1	Carbuncle 01/2024
1	Pharyngitis (Sore Throat) 01/2024
1	Endotoxemia 07/2023
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 04/2023
1	Cognitive Dysfunction 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Listeriosis (Listeria Infection) 12/2021
1	Diabetic Angiopathies (Diabetic Angiopathy) 11/2021

Drug/Important Bio-Agent (IBA)

41	HMGB1 Protein (HMG1)IBA 07/2023 - 12/2007
14	Monoclonal AntibodiesIBA 01/2024 - 12/2007
12	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 01/2004
7	histidine-rich proteinsIBA 04/2023 - 11/2009
7	Histidine (L-Histidine)FDA Link 02/2011 - 02/2004
5	Advanced Glycation End ProductsIBA 11/2021 - 03/2010
5	Therapeutic UsesIBA 06/2020 - 01/2009
4	LipopolysaccharidesIBA 07/2023 - 04/2016
4	Proteins (Proteins, Gene)FDA Link 08/2022 - 02/2011
4	CytokinesIBA 08/2022 - 02/2011
4	Nuclear Proteins (Protein, Nuclear)IBA 01/2022 - 01/2016
4	Toll-Like Receptor 4IBA 01/2019 - 01/2016
3	Minocycline (Cyclops)FDA LinkGeneric 01/2022 - 12/2017
3	glycolaldehydeIBA 11/2021 - 09/2009
3	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2004
3	Neutralizing AntibodiesIBA 01/2019 - 02/2011
3	Receptor for Advanced Glycation End ProductsIBA 12/2017 - 01/2016
3	GlyceraldehydeIBA 08/2017 - 09/2009
3	thioperamideIBA 09/2008 - 12/2005
3	Dopamine (Intropin)FDA LinkGeneric 10/2007 - 01/2004
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 01/2019
2	Clodronic Acid (Clodronate)IBA 01/2022 - 12/2017
2	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2022 - 10/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 09/2020
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 01/2019
2	GlucocorticoidsIBA 01/2020 - 12/2002
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2018 - 01/2016
2	ThrombomodulinIBA 12/2017 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2016
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 03/2007
2	metoprineIBA 03/2007 - 12/2005
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 03/2007 - 02/2007
2	Histamine H2 ReceptorsIBA 03/2007 - 03/2005
1	CollagenIBA 01/2024
1	PolyaminesIBA 01/2024
1	Liposomes (Liposome)IBA 01/2022
1	AcidsIBA 01/2022
1	p-Methoxy-N-methylphenethylamineIBA 01/2022
1	ChromatinIBA 01/2022
1	CalciumIBA 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Histones (Histone)IBA 10/2021
1	AlarminsIBA 04/2021
1	AcetoneIBA 04/2021
1	mirogabalinIBA 04/2021

Therapy/Procedure

11	Ligation 08/2022 - 03/2007
11	Therapeutics 01/2022 - 05/2011
5	Intravenous Injections 07/2023 - 12/2007
4	Injections 01/2022 - 02/2007
3	Intraperitoneal Injections 08/2022 - 10/2018
1	Traditional Medicine (Folk Remedies) 01/2024